First- and Second-Trimester Evaluation of Risk for Down Syndrome

@article{Ball2007FirstAS,
  title={First- and Second-Trimester Evaluation of Risk for Down Syndrome},
  author={R. Ball and A. Caughey and F. Malone and D. Nyberg and C. Comstock and G. Saade and R. Berkowitz and S. Gross and Lorraine Dugoff and S. Craigo and I. Timor-Tritsch and S. Carr and H. Wolfe and D. Emig and M. D'Alton},
  journal={Obstetrics & Gynecology},
  year={2007},
  volume={110},
  pages={10-17}
}
  • R. Ball, A. Caughey, +12 authors M. D'Alton
  • Published 2007
  • Medicine
  • Obstetrics & Gynecology
    • OBJECTIVE: To investigate the differences in costs and outcomes of Down syndrome screening using data from the First and Second Trimester Evaluation of Risk (FASTER) Trial. METHODS: Seven possible screening options for Down syndrome were compared: 1) Triple Screen—maternal serum alpha fetoprotein, estriol, and hCG; 2) Quad—maternal serum alpha fetoprotein, estriol, hCG, and Inhibin A; 3) Combined First—nuchal translucency, pregnancy-associated plasma protein A (PAPP-A), free &bgr;-hCG; 4… CONTINUE READING
    View on Wolters Kluwer
    bollettino-emiliaromagna.it
    Top 3 of 87 Citations
    Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population
    K. Song, T. Musci, A. CaugheyThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2013
    96
    Non‐invasive prenatal testing for aneuploidy: current status and future prospects
    P. Benn, H. Cuckle, E. PergamentUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology2013
    226
    Comparison of different strategies in prenatal screening for Down’s syndrome: cost effectiveness analysis of computer simulation
    J. Gekas, G. Gagne, … F. RousseauBMJ : British Medical Journal2009
    55
    87 Citations
    Citation Type

    Citation Type

    Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population
    • 96
    Non‐invasive prenatal testing for aneuploidy: current status and future prospects
    • 226
    • PDF
    Comparison of different strategies in prenatal screening for Down’s syndrome: cost effectiveness analysis of computer simulation
    • 55
    • PDF
    Screening for adverse pregnancy outcome at early gestational age.
    • 25
    First trimester serum tests for Down's syndrome screening.
    • 27
    • PDF
    First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
    • 21
    First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.
    • 11
    Cost-effectiveness and accuracy of prenatal Down syndrome screening strategies: should the combined test continue to be widely used?
    • 22
    • PDF
    Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists.
    • 28
    Beyond the first trimester screen: Can we predict who will choose invasive testing?
    • 11
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 36 REFERENCES
    First-trimester or second-trimester screening, or both, for Down's syndrome.
    • 500
    • PDF
    Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    • 432
    First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).
    • 664
    • PDF
    Combining Ultrasound and Biochemistry in First‐Trimester Screening for Down's syndrome
    • 250
    Sequential Pathways of Testing After First-Trimester Screening for Trisomy 21
    • 77
    Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.
    • 154
    • PDF
    An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
    • 65
    First-trimester screening for trisomies 21 and 18.
    • 146
    • PDF
    Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis.
    • 58
    • PDF
    Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    • 852
    • PDF